BCL2 and intrahepatic cholangiocarcinoma: In addition, Gem and SFN-mediated HDAC inhibition caused increased Bax expression and decreased Bcl-2 expression in intrahepatic cholangiocarcinoma HuCCT-1 and HuH28 cells [40].